Optimising Triple Therapy in uHCC : Critical Considerations on Sequencing, Efficacy Endpoints and Statistical Robustness

Key Points

• The aim is to evaluate the optimal sequencing and effectiveness of triple therapy for uHCC.
• Analysis of critical factors affecting treatment sequencing.
• Evaluation of efficacy endpoints relevant to patient outcomes.
• Assessment of statistical robustness for the proposed treatment protocols.
• Identified key considerations for improving treatment effectiveness.
• Highlighted the importance of sequencing therapies for better outcomes.
• Discussed the implications of statistical robustness on treatment decisions.